Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-11 · accession 0001104659-23-022114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-14 | RYTM | Shulman Joseph | Chief Technical Off | S - Sale+OE | $26.87 | -554 | 3,741 | -13% | -$14.9K |
| D | 2023-02-14 | 2023-02-11 | RYTM | Shulman Joseph | Chief Technical Off | M - OptEx | — | +1,563 | 4,295 | +57% | — |
| D | 2023-02-14 | 2023-02-11 | RYTM | Shulman Joseph | Chief Technical Off | M - OptEx | $0.00 | -1,563 | 3,124 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | S | D | 554 | $26.87 | 3,741 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-11 | M | A | 1,563 | — | 4,295 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 3 | Derivative | Restricted Stock Units | 2023-02-11 | M | D | 1,563 | $0.00 | 3,124 | D | — · — to — | 1,563 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. |